Arginine metabolic endotypes related to asthma severity.
<h4>Aims</h4>Arginine metabolism via inducible nitric oxide synthase (iNOS) and arginase 2 (ARG2) is higher in asthmatics than in healthy individuals. We hypothesized that a sub-phenotype of asthma might be defined by the magnitude of arginine metabolism categorized on the basis of high...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183066&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850230386965086208 |
|---|---|
| author | Weiling Xu Suzy A A Comhair Allison J Janocha Abigail Lara Lori A Mavrakis Carole D Bennett Satish C Kalhan Serpil C Erzurum |
| author_facet | Weiling Xu Suzy A A Comhair Allison J Janocha Abigail Lara Lori A Mavrakis Carole D Bennett Satish C Kalhan Serpil C Erzurum |
| author_sort | Weiling Xu |
| collection | DOAJ |
| description | <h4>Aims</h4>Arginine metabolism via inducible nitric oxide synthase (iNOS) and arginase 2 (ARG2) is higher in asthmatics than in healthy individuals. We hypothesized that a sub-phenotype of asthma might be defined by the magnitude of arginine metabolism categorized on the basis of high and low fraction of exhaled nitric oxide (FENO).<h4>Methods</h4>To test this hypothesis, asthmatics (n = 52) were compared to healthy controls (n = 51) for levels of FENO, serum arginase activity, and airway epithelial expression of iNOS and ARG2 proteins, in relation to clinical parameters of asthma inflammation and airway reactivity. In parallel, bronchial epithelial cells were evaluated for metabolic effects of iNOS and ARG2 expression in vitro.<h4>Results</h4>Asthmatics with high FENO (≥ 35 ppb; 44% of asthmatics) had higher expression of iNOS (P = 0.04) and ARG2 (P = 0.05) in the airway, indicating FENO is a marker of the high arginine metabolic endotype. High FENO asthmatics had the lowest FEV1% (P < 0.001), FEV1/FVC (P = 0.0002) and PC20 (P < 0.001) as compared to low FENO asthmatics or healthy controls. Low FENO asthmatics had near normal iNOS and ARG2 expression (both P > 0.05), and significantly higher PC20 (P < 0.001) as compared to high FENO asthmatics. In vitro studies to evaluate metabolic effects showed that iNOS overexpression and iNOS+ARG2 co-expression in a human bronchial epithelial cell line led to greater reliance on glycolysis with higher rate of pyruvate going to lactate.<h4>Conclusions</h4>The high FENO phenotype represents a large portion of the asthma population, and is typified by greater arginine metabolism and more severe and reactive asthma. |
| format | Article |
| id | doaj-art-704fda2e6cc14b05ba11f2eda5e50f19 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-704fda2e6cc14b05ba11f2eda5e50f192025-08-20T02:03:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018306610.1371/journal.pone.0183066Arginine metabolic endotypes related to asthma severity.Weiling XuSuzy A A ComhairAllison J JanochaAbigail LaraLori A MavrakisCarole D BennettSatish C KalhanSerpil C Erzurum<h4>Aims</h4>Arginine metabolism via inducible nitric oxide synthase (iNOS) and arginase 2 (ARG2) is higher in asthmatics than in healthy individuals. We hypothesized that a sub-phenotype of asthma might be defined by the magnitude of arginine metabolism categorized on the basis of high and low fraction of exhaled nitric oxide (FENO).<h4>Methods</h4>To test this hypothesis, asthmatics (n = 52) were compared to healthy controls (n = 51) for levels of FENO, serum arginase activity, and airway epithelial expression of iNOS and ARG2 proteins, in relation to clinical parameters of asthma inflammation and airway reactivity. In parallel, bronchial epithelial cells were evaluated for metabolic effects of iNOS and ARG2 expression in vitro.<h4>Results</h4>Asthmatics with high FENO (≥ 35 ppb; 44% of asthmatics) had higher expression of iNOS (P = 0.04) and ARG2 (P = 0.05) in the airway, indicating FENO is a marker of the high arginine metabolic endotype. High FENO asthmatics had the lowest FEV1% (P < 0.001), FEV1/FVC (P = 0.0002) and PC20 (P < 0.001) as compared to low FENO asthmatics or healthy controls. Low FENO asthmatics had near normal iNOS and ARG2 expression (both P > 0.05), and significantly higher PC20 (P < 0.001) as compared to high FENO asthmatics. In vitro studies to evaluate metabolic effects showed that iNOS overexpression and iNOS+ARG2 co-expression in a human bronchial epithelial cell line led to greater reliance on glycolysis with higher rate of pyruvate going to lactate.<h4>Conclusions</h4>The high FENO phenotype represents a large portion of the asthma population, and is typified by greater arginine metabolism and more severe and reactive asthma.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183066&type=printable |
| spellingShingle | Weiling Xu Suzy A A Comhair Allison J Janocha Abigail Lara Lori A Mavrakis Carole D Bennett Satish C Kalhan Serpil C Erzurum Arginine metabolic endotypes related to asthma severity. PLoS ONE |
| title | Arginine metabolic endotypes related to asthma severity. |
| title_full | Arginine metabolic endotypes related to asthma severity. |
| title_fullStr | Arginine metabolic endotypes related to asthma severity. |
| title_full_unstemmed | Arginine metabolic endotypes related to asthma severity. |
| title_short | Arginine metabolic endotypes related to asthma severity. |
| title_sort | arginine metabolic endotypes related to asthma severity |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183066&type=printable |
| work_keys_str_mv | AT weilingxu argininemetabolicendotypesrelatedtoasthmaseverity AT suzyaacomhair argininemetabolicendotypesrelatedtoasthmaseverity AT allisonjjanocha argininemetabolicendotypesrelatedtoasthmaseverity AT abigaillara argininemetabolicendotypesrelatedtoasthmaseverity AT loriamavrakis argininemetabolicendotypesrelatedtoasthmaseverity AT caroledbennett argininemetabolicendotypesrelatedtoasthmaseverity AT satishckalhan argininemetabolicendotypesrelatedtoasthmaseverity AT serpilcerzurum argininemetabolicendotypesrelatedtoasthmaseverity |